162 related articles for article (PubMed ID: 20597077)
1. Measurement of airway ion transport assists the diagnosis of cystic fibrosis.
Middleton PG; House HH
Pediatr Pulmonol; 2010 Aug; 45(8):789-95. PubMed ID: 20597077
[TBL] [Abstract][Full Text] [Related]
2. Protocols for in vivo measurement of the ion transport defects in cystic fibrosis nasal epithelium.
Middleton PG; Geddes DM; Alton EW
Eur Respir J; 1994 Nov; 7(11):2050-6. PubMed ID: 7875281
[TBL] [Abstract][Full Text] [Related]
3. The CF-CIRC study: a French collaborative study to assess the accuracy of cystic fibrosis diagnosis in neonatal screening.
Sermet-Gaudelus I; Roussel D; Bui S; Deneuville E; Huet F; Reix P; Bellon G; Lenoir G; Edelman A
BMC Pediatr; 2006 Oct; 6():25. PubMed ID: 17018149
[TBL] [Abstract][Full Text] [Related]
4. A modified technique for measurement of nasal transepithelial potential difference in infants.
Southern KW; Noone PG; Bosworth DG; Legrys VA; Knowles MR; Barker PM
J Pediatr; 2001 Sep; 139(3):353-8. PubMed ID: 11562613
[TBL] [Abstract][Full Text] [Related]
5. The in vivo effects of milrinone on the airways of cystic fibrosis mice and human subjects.
Smith SN; Middleton PG; Chadwick S; Jaffe A; Bush KA; Rolleston S; Farley R; Delaney SJ; Wainwright B; Geddes DM; Alton EW
Am J Respir Cell Mol Biol; 1999 Jan; 20(1):129-34. PubMed ID: 9870926
[TBL] [Abstract][Full Text] [Related]
6. Impact of different chloride and glucose solutions on nasal potential difference.
House HH; Middleton PG
Pediatr Pulmonol; 2009 Jul; 44(7):645-8. PubMed ID: 19514053
[TBL] [Abstract][Full Text] [Related]
7. Amiloride-insensitive nasal potential difference varies with the menstrual cycle in cystic fibrosis.
Sweezey NB; Smith D; Corey M; Ellis L; Carpenter S; Tullis DE; Durie P; O'Brodovich HM
Pediatr Pulmonol; 2007 Jun; 42(6):519-24. PubMed ID: 17469152
[TBL] [Abstract][Full Text] [Related]
8. The effect of varying tonicity on nasal epithelial ion transport in cystic fibrosis.
Davies MG; Geddes DM; Alton EW
Am J Respir Crit Care Med; 2005 Apr; 171(7):760-3. PubMed ID: 15618459
[TBL] [Abstract][Full Text] [Related]
9. Standardized procedure for measurement of nasal potential difference: an outcome measure in multicenter cystic fibrosis clinical trials.
Standaert TA; Boitano L; Emerson J; Milgram LJ; Konstan MW; Hunter J; Berclaz PY; Brass L; Zeitlin PL; Hammond K; Davies Z; Foy C; Noone PG; Knowles MR
Pediatr Pulmonol; 2004 May; 37(5):385-92. PubMed ID: 15095320
[TBL] [Abstract][Full Text] [Related]
10. Relative ion permeability of normal and cystic fibrosis nasal epithelium.
Knowles M; Gatzy J; Boucher R
J Clin Invest; 1983 May; 71(5):1410-7. PubMed ID: 6853720
[TBL] [Abstract][Full Text] [Related]
11. [Measurement of nasal transepithelial potential difference: a diagnostic test for cystic fibrosis].
Charfi MR; Matran R; Regnard J; Lockhart A
Rev Pneumol Clin; 1996; 52(1):9-13. PubMed ID: 8731749
[TBL] [Abstract][Full Text] [Related]
12. Activation by extracellular nucleotides of chloride secretion in the airway epithelia of patients with cystic fibrosis.
Knowles MR; Clarke LL; Boucher RC
N Engl J Med; 1991 Aug; 325(8):533-8. PubMed ID: 1857389
[TBL] [Abstract][Full Text] [Related]
13. A multicenter study of the effect of solution temperature on nasal potential difference measurements.
Boyle MP; Diener-West M; Milgram L; Knowles M; Foy C; Zeitlin P; Standaert T;
Chest; 2003 Aug; 124(2):482-9. PubMed ID: 12907532
[TBL] [Abstract][Full Text] [Related]
14. Abnormal apical cell membrane in cystic fibrosis respiratory epithelium. An in vitro electrophysiologic analysis.
Cotton CU; Stutts MJ; Knowles MR; Gatzy JT; Boucher RC
J Clin Invest; 1987 Jan; 79(1):80-5. PubMed ID: 3793933
[TBL] [Abstract][Full Text] [Related]
15. Increased contact time improves adenovirus-mediated CFTR gene transfer to nasal epithelium of CF mice.
Jiang C; Akita GY; Colledge WH; Ratcliff RA; Evans MJ; Hehir KM; St George JA; Wadsworth SC; Cheng SH
Hum Gene Ther; 1997 Apr; 8(6):671-80. PubMed ID: 9113507
[TBL] [Abstract][Full Text] [Related]
16. Effect of macrolides on in vivo ion transport across cystic fibrosis nasal epithelium.
Barker PM; Gillie DJ; Schechter MS; Rubin BK
Am J Respir Crit Care Med; 2005 Apr; 171(8):868-71. PubMed ID: 15657462
[TBL] [Abstract][Full Text] [Related]
17. Measurement of nasal potential difference in young children with an equivocal sweat test following newborn screening for cystic fibrosis.
Sermet-Gaudelus I; Girodon E; Roussel D; Deneuville E; Bui S; Huet F; Guillot M; Aboutaam R; Renouil M; Munck A; des Georges M; Iron A; Thauvin-Robinet C; Fajac I; Lenoir G; Roussey M; Edelman A
Thorax; 2010 Jun; 65(6):539-44. PubMed ID: 20522854
[TBL] [Abstract][Full Text] [Related]
18. Modified method to measure nasal potential difference.
Leal T; Lebacq J; Lebecque P; Cumps J; Wallemacq P
Clin Chem Lab Med; 2003 Jan; 41(1):61-7. PubMed ID: 12636051
[TBL] [Abstract][Full Text] [Related]
19. Nasal potential difference: a clinical diagnostic test for cystic fibrosis.
Alton EW; Currie D; Logan-Sinclair R; Warner JO; Hodson ME; Geddes DM
Eur Respir J; 1990 Sep; 3(8):922-6. PubMed ID: 2292287
[TBL] [Abstract][Full Text] [Related]
20. Quantitative fluorescence measurements of chloride secretion in native airway epithelium from CF and non-CF subjects.
Stern M; Munkonge FM; Caplen NJ; Sorgi F; Huang L; Geddes DM; Alton EW
Gene Ther; 1995 Dec; 2(10):766-74. PubMed ID: 8750017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
